For some “cancer genes”, the type of FMCR (deleted or amplified) was not consistent with the known gene function, an example being the deletion of the known oncogene NRAS. However, the gene function and the type of the FMCR were often consistent with expectation, examples including deletions of MAP2K4 and CDKN2C (Table S2 in File S1) and gain of FGFR1 (Table S3 in File S1). This evidence concerns the gene NRAS and cancer.